In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bayer Extra Strength Aspirin for Migraine Pain Drug Master File in Korea (Bayer Extra Strength Aspirin for Migraine Pain KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bayer Extra Strength Aspirin for Migraine Pain. The MFDS reviews the Bayer Extra Strength Aspirin for Migraine Pain KDMF as part of the drug registration process and uses the information provided in the Bayer Extra Strength Aspirin for Migraine Pain KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bayer Extra Strength Aspirin for Migraine Pain KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bayer Extra Strength Aspirin for Migraine Pain API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bayer Extra Strength Aspirin for Migraine Pain suppliers with KDMF on PharmaCompass.